GOLDFARB DAVID has a total of 15 patent applications. Its first patent ever was published in 1974. It filed its patents most often in Canada, Japan and United States. Its main competitors in its focus markets medical technology and pharmaceuticals are LIFECELL CORP, SELLIN LOTHAR and EMODIAL S R L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | Japan | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Switzerland | 1 | |
#6 | Germany | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Spain | 1 | |
#9 | France | 1 | |
#10 | United Kingdom | 1 | |
#11 | Netherlands | 1 | |
#12 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Object sterilising | |
#3 | Electrotherapy | |
#4 | Medical preparations | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Goldfarb David | 8 |
#2 | Deebitsudo Goorudofuaabu | 2 |
Publication | Filing date | Title |
---|---|---|
US2021038891A1 | Apparatus and Method for Treating Obstructive Sleep Apnea | |
US2016106743A1 | Topoisomerase ii poisons and methods of making and using same | |
CA1147087A | Graphite impregnated prosthetic vascular graft materials | |
AU7686874A | Prosthetic vascular graft |